Edwards Lifesciences Corp EW

Edwards Lifesciences Corp is a global medical technology company that focuses on developing heart valves and hemodynamic monitoring systems. It was founded in 1958 with its headquarters in Irvine, California. It operates and supplies products to around 100 countries worldwide.

Edwards Lifesciences is dedicated to improving and providing technology for patients fighting cardiovascular disease and critical illness. In doing so, it partners with physicians to design products that can help patients experiencing cardiovascular difficulties live longer and more productive lives. These products are also created to address the significant number of unmet clinical needs. In 2021, it received more than five awards and recognitions, including being among the Just Capital's Top 100 Companies Supporting Healthy Families and Communities and winning 2021 World's Most Ethical Companies award for the 5th consecutive year.

Edwards Lifesciences not only provides products for cardiovascular issues but also offers therapy services for blood conservation, enhanced surgical recovery, clot management, and more. It supplies products in four main areas: transcatheter aortic valve replacement, transcatheter mitral and tricuspid therapies, surgical structural heart, and critical care. It has been trading on the NYSE since 2000 under the ticker EW.

Stay up to date on the share price of Edwards Life Sciences by adding EW stock to your eToro watchlist.